250 related articles for article (PubMed ID: 28283801)
21. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
[TBL] [Abstract][Full Text] [Related]
22. Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.
Hallal S; Ebrahim Khani S; Wei H; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668808
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas.
Kuriyama H; Lamborn KR; O'Fallon JR; Iturria N; Sebo T; Schaefer PL; Scheithauer BW; Buckner JC; Kuriyama N; Jenkins RB; Israel MA
Neuro Oncol; 2002 Jul; 4(3):179-86. PubMed ID: 12084348
[TBL] [Abstract][Full Text] [Related]
24. [Serum amyloid A (SAA)--pathogenicity and implication of appearance in plasma].
Yamada T
Rinsho Byori; 2006 May; 54(5):509-12. PubMed ID: 16789422
[TBL] [Abstract][Full Text] [Related]
25. Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma.
Vietheer JM; Rieger J; Wagner M; Senft C; Tichy J; Foerch C
J Neurooncol; 2017 Oct; 135(1):193-199. PubMed ID: 28717884
[TBL] [Abstract][Full Text] [Related]
26. Serum alpha 2-HS glycoprotein predicts survival in patients with glioblastoma.
Petrik V; Saadoun S; Loosemore A; Hobbs J; Opstad KS; Sheldon J; Tarelli E; Howe FA; Bell BA; Papadopoulos MC
Clin Chem; 2008 Apr; 54(4):713-22. PubMed ID: 18281421
[TBL] [Abstract][Full Text] [Related]
27. Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA.
Xu Y; Yamada T; Satoh T; Okuda Y
Clin Chem Lab Med; 2006; 44(1):59-63. PubMed ID: 16375587
[TBL] [Abstract][Full Text] [Related]
28. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
29. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.
Rempel SA; Dudas S; Ge S; Gutiérrez JA
Clin Cancer Res; 2000 Jan; 6(1):102-11. PubMed ID: 10656438
[TBL] [Abstract][Full Text] [Related]
30. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
Tanwar MK; Gilbert MR; Holland EC
Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
[TBL] [Abstract][Full Text] [Related]
32. CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas.
Suren D; Isiksacan Ozen O
J BUON; 2013; 18(4):1006-11. PubMed ID: 24344030
[TBL] [Abstract][Full Text] [Related]
33. Serum amyloid A1 levels and amyloid deposition following a high-fat diet challenge in transgenic mice overexpressing hepatic serum amyloid A1.
Jang WY; Jeong J; Kim S; Kang MC; Sung YH; Choi M; Park SJ; Kim MO; Kim SH; Ryoo ZY
Appl Physiol Nutr Metab; 2016 Jun; 41(6):640-8. PubMed ID: 27218680
[TBL] [Abstract][Full Text] [Related]
34. Serum amyloid A expression in the breast cancer tissue is associated with poor prognosis.
Yang M; Liu F; Higuchi K; Sawashita J; Fu X; Zhang L; Zhang L; Fu L; Tong Z; Higuchi K
Oncotarget; 2016 Jun; 7(24):35843-35852. PubMed ID: 27058895
[TBL] [Abstract][Full Text] [Related]
35. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
[TBL] [Abstract][Full Text] [Related]
36. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
[TBL] [Abstract][Full Text] [Related]
37. Tissue-specific regulation of the human acute-phase serum amyloid A genes, SAA1 and SAA2, by glucocorticoids in hepatic and epithelial cells.
Thorn CF; Lu ZY; Whitehead AS
Eur J Immunol; 2003 Sep; 33(9):2630-9. PubMed ID: 12938239
[TBL] [Abstract][Full Text] [Related]
38. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
[TBL] [Abstract][Full Text] [Related]
39. Serum amyloid A1 alleles and plasma concentrations of serum amyloid A.
Yamada T; Wada A; Itoh Y; Itoh K
Amyloid; 1999 Sep; 6(3):199-204. PubMed ID: 10524285
[TBL] [Abstract][Full Text] [Related]
40. Twist predicts poor outcome of patients with astrocytic glioma.
Nordfors K; Haapasalo J; Mäkelä K; Granberg KJ; Nykter M; Korja M; Paavonen T; Haapasalo H; Soini Y
J Clin Pathol; 2015 Nov; 68(11):905-12. PubMed ID: 26163539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
